Health CarePharmaceuticals & Biotechnology
  • Price (USD)23.39
  • Today's Change0.255 / 1.10%
  • Shares traded3.78m
  • 1 Year change-26.81%
  • Beta0.7112
Data delayed at least 15 minutes, as of Jul 18 2018 16:59 BST.
More ▼

Key statistics

As of last trade Teva Pharmaceutical Industries Ltd (TEVA:NYQ) traded at 23.39, -29.65% below its 52-week high of 33.24, set on Jul 27, 2017.
52-week range
10.85Nov 02 201733.24Jul 27 2017
Markit short selling activity
Previous close23.13
Average volume7.93m
Shares outstanding1.02bn
Free float977.12m
P/E (TTM)--
Market cap23.67bn USD
EPS (TTM)-16.84
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateNov 27 2017
Div pay-dateDec 12 2017
Data delayed at least 15 minutes, as of Jul 18 2018 16:59 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.